Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of fidaxomicin powder in China. We warmly welcome yuo to wholesale bulk fidaxomicin powder for sale here from our factory. Quality products and reasonable price are available.
What Does FidaxoMicin Do
Fidaxomicin Powder is an antibiotic medication used to treat infections caused by the bacteria Clostridium difficile, commonly known as C. difficile. C. difficile infection (CDI) can lead to severe gastrointestinal symptoms, including diarrhea and inflammation of the colon, particularly in hospitalized patients or those recently treated with antibiotics.

It is classified as a macrocyclic antibiotic and inhibits protein synthesis in C. difficile bacteria. It targets and binds to a specific RNA polymerase enzyme essential for bacterial growth and replication. By inhibiting this enzyme, fidaxomicin prevents the synthesis of bacterial proteins necessary for the bacteria's survival and reproduction.
Several critical characteristics of fidaxomicin contribute to its effectiveness in treating CDI. First, it has a narrow spectrum of activity, meaning it targets explicitly C. difficile bacteria and does not affect the normal gut flora as extensively as broad-spectrum antibiotics. This selective targeting helps to minimize the disruption of the beneficial bacteria in the intestine and reduces the risk of recurrent infections.
Because this pharmaceutical intermediate plays an essential role in various fields of medicine, it has become a star product of different domestic suppliers, large and small. When faced with so many choices, the quality of the product has become the main factor attracting customers. As a large-scale manufacturer in China, Xi'an Sonwu is not only able to provide high-purity raw powder but also the most favorable prices.
Certificate of Analysis
|
ANALYSIS |
SPECIFICATION |
RESULT |
|
Characters |
White to off-white powder |
Qualified |
|
Identification |
Meets the requirements |
Qualified |
|
Appearance of solution meets |
s the requirements |
Qualified |
|
Organic volatile impurities |
Qualified |
Qualified |
|
Solubility |
Chloroform (Slightly, Heated), DMSO (Slightly, Heated), Methanol (Slightly) |
Qualified |
|
Loss on drying |
≤0.5% |
0.15% |
|
Residue on ignition |
≤0.1% |
0.05% |
|
Heavy metal |
≤15ppm |
3ppm |
|
Lead(Pb) |
≤1ppm |
Qualified |
|
Arsenic(As) |
≤2ppm |
Qualified |
|
Mercury(Hg) |
Not detected |
Not detected |
|
Assay |
NLT99% |
99.41% |
|
Conclusion |
This product complies with international standards |
|
Where To Buy PAR-101
Xi'an Sonwu Biotech Co. Ltd. has rich involvement with the worldwide exchange and wellbeing industry. Demanding religion and quality initially is our organization's rule. We rigorously control item quality, and that implies determination begins from unrefined substances. Furthermore, we handle everything about diminishing the expense for the greatest so our clients can get a savvy item. Given these, clients have given a lot of good criticism to our items. So, search for Xi'an Sonwu Biotech Co. Ltd. while purchasing PAR-101.
Xi’an Sonwu ensures the product’s quality so samples can be supplied. Here is the quantity.
|
Form |
Sample Amount |
The Minimum of Quantity |
|
Powder |
5g |
10g |
|
Bulk Capsules |
200 capsules |
200 capsules |
|
Bottled Capsules |
5 bottles |
5 bottles |
Customers' Good Comment

OEM Service
Xi'an Sonwu not only can supply high-quality FidaxoMicin Powder but also supply its capsules.
So, any customers could customize the capsules they want. The items are as follows.
1. Customized capsules shells (size, color, material)
2. Customized bottles(size, color, material, style)
3. Customized packaging(vacuum foil packaging, box, drum)
4. Customized label(paint film, matte film, optical mask)
Is Fidaxomicin A Macrolide
PAR-101 is not a macrolide antibiotic. It belongs to a different class of antibiotics called macrocyclic antibiotics.
Macrolide antibiotics, such as azithromycin, clarithromycin, and erythromycin, are characterized by a large macrocyclic lactone ring structure. They inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of functional peptide chains. Macrolides are broad-spectrum antibiotics effective against a wide range of Gram-positive and some Gram-negative bacteria, and they are commonly used to treat respiratory tract infections, skin infections, and sexually transmitted infections.

On the other hand, fidaxomicin belongs to the macrocyclic antibiotic class. It is derived from the fermentation product of the soil bacterium Dactylosporangium aurantiacum. Although fidaxomicin and macrolides share some structural similarities and both have a macrocyclic ring structure, they differ in their mechanism of action and spectrum of activity.
Importantly, fidaxomicin has a narrow spectrum of activity primarily limited to C. difficile. It has minimal activity against other bacteria, including those commonly associated with respiratory or skin infections. This focused antimicrobial activity helps to selectively target the C. difficile bacteria without disrupting the normal gut microbiota as extensively as broad-spectrum antibiotics.
In conclusion, fidaxomicin is not a macrolide antibiotic but belongs to the macrocyclic antibiotic class. It acts by inhibiting the bacterial RNA polymerase, specifically targeting Clostridium difficile bacteria in the treatment of C. difficile infection.
Why Is Fidaxomicin Used
It is primarily used for the treatment of Clostridium difficile infection (CDI), which is a bacterial infection that commonly affects the gastrointestinal tract. Here are several key reasons why fidaxomicin is used:
1. Effectiveness against Clostridium difficile: Fidaxomicin has demonstrated efficacy in treating CDI. It specifically targets and inhibits the growth of Clostridium difficile bacteria, which are responsible for causing the infection. Fidaxomicin works by inhibiting bacterial RNA polymerase, a vital enzyme involved in bacterial replication. By blocking RNA synthesis, fidaxomicin disrupts protein production, ultimately suppressing the growth of Clostridium difficile bacteria and helping to resolve the infection.
2. Reduced risk of recurrence: One of the distinguishing features of fidaxomicin is its lower rate of recurrence compared to other antibiotics commonly used to treat CDI, such as vancomycin. Fidaxomicin's mechanism of action and selective targeting of Clostridium difficile help to minimize disruption to the normal gut microbiota. This may contribute to a reduced risk of recurrence and a higher likelihood of sustained clinical cure.
3. Preservation of the gut microbiota: Fidaxomicin has a narrower spectrum of activity compared to broad-spectrum antibiotics. It primarily targets Clostridium difficile, while having limited impact on the normal gut microbiota. This is important because the gut microbiota plays a crucial role in maintaining overall health, including digestion, metabolism, and immune function. By preserving the diversity and balance of the gut microbiota, fidaxomicin may help limit the adverse effects often associated with antibiotic treatment.
Fidaxomicin Dosage
The dosage of fidaxomicin for the treatment of Clostridium difficile infection (CDI) is typically as follows:
Adults: The recommended dose for adults is 200 mg (one tablet) of fidaxomicin orally twice daily for 10 days.
Pediatric Patients: The use of fidaxomicin in pediatric patients is limited, and dosing recommendations may vary based on the child's age, weight, and specific clinical circumstances. Generally, the dosage for children is based on weight, with a maximum daily dose of 200 mg.
For children weighing less than 12.5 kg (27.5 lbs), the dose is 4 mg/kg orally twice daily for 10 days.
For children weighing 12.5 kg (27.5 lbs) or more, the recommended adult dose may be used.
It is important to follow the dosing instructions provided by the healthcare professional, as they may tailor the dosage based on factors such as the severity of the infection, the patient's age, and any comorbid conditions.
As always, it is crucial to consult with a healthcare professional, such as a doctor or pharmacist, for the correct dosage and guidance specific to the patient's condition. They can provide personalized recommendations and ensure the safe and effective use of fidaxomicin.
Factory Environment

Certifications

Logistics

In addition to guaranteeing product quality, the other most vital thing is clients can receive the goods smoothly. So, Xi’an Sonwu supplies all kinds of couriers according to different needs.

Company's Profile
Xi’an Sonwu Biotech Co . Itd is a professional Chinese manufacturer and products supplier. It was founded in 2012 in the Hi-Tech industrial Zone of Xi’an city, Shannxi Province, China. It pays all attention to the development, research, and production of food additives, plant extract, APl, and other ingredients of health care products. Our company supplies five raw material products: Anti-hair loss Powders, Nootropic, API, Muscle Building products, and Plant Extract. We sincerely believe that the premise of excellent cooperation is the best services and good quality. So, welcome your inquiry.
If you want to know the FidaxoMicin Powder price, please don't hesitate to contact us via:
E-mail: sales@sonwu.com
Hot Tags: fidaxomicin powder, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, Zinc Carnosine Powder, CDCA powder, AB1010 Powder, Atazanavir API, Argatroban Powder, Glyceryl glucoside liquid
















